Bicifadine: Phase II started

DOVP began a double-blind, placebo-controlled, 4-way crossover, U.S. Phase II trial in 60 patients. Each patient will receive bicifadine, ibuprofen, bicifadine plus ibuprofen and placebo for one week ...